Year All2025202420232022202120202019 Jan 13, 2025 Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones Jan 08, 2025 Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference Jan 03, 2025 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Nov 29, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Nov 05, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results Nov 01, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Oct 02, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Sep 03, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Aug 08, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results Aug 02, 2024 Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Nov 05, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
Aug 08, 2024 Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
